0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Preventive Medicine for Pets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-4I13087
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Preventive Medicine for Pets Market Research Report 2023
BUY CHAPTERS

Preventive Medicine for Pets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4I13087
Report
September 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Preventive Medicine for Pets - Market Size

The global market for Preventive Medicine for Pets was estimated to be worth US$ 945 million in 2023 and is forecast to a readjusted size of US$ 1583.7 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Preventive Medicine for Pets - Market

Preventive Medicine for Pets - Market

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Preventive Medicine for Pets, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Preventive Medicine for Pets by region & country, by Type, and by Application.
The Preventive Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Medicine for Pets.
Market Segmentation

Scope of Preventive Medicine for Pets - Market Report

Report Metric Details
Report Name Preventive Medicine for Pets - Market
Forecasted market size in 2030 US$ 1583.7 million
CAGR 8.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Powder
  • Liquid
Segment by Application
  • Cat
  • Dog
  • Reptile
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Preventive Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Preventive Medicine for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Preventive Medicine for Pets in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Preventive Medicine for Pets - Market size in 2030?

Ans: The Preventive Medicine for Pets - Market size in 2030 will be US$ 1583.7 million.

Who are the main players in the Preventive Medicine for Pets - Market report?

Ans: The main players in the Preventive Medicine for Pets - Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Wuhan chopperlvya, CAHIC

What are the Application segmentation covered in the Preventive Medicine for Pets - Market report?

Ans: The Applications covered in the Preventive Medicine for Pets - Market report are Cat, Dog, Reptile, Other

What are the Type segmentation covered in the Preventive Medicine for Pets - Market report?

Ans: The Types covered in the Preventive Medicine for Pets - Market report are Powder, Liquid

1 Market Overview
1.1 Preventive Medicine for Pets Product Introduction
1.2 Global Preventive Medicine for Pets Market Size Forecast
1.2.1 Global Preventive Medicine for Pets Sales Value (2019-2030)
1.2.2 Global Preventive Medicine for Pets Sales Volume (2019-2030)
1.2.3 Global Preventive Medicine for Pets Sales Price (2019-2030)
1.3 Preventive Medicine for Pets Market Trends & Drivers
1.3.1 Preventive Medicine for Pets Industry Trends
1.3.2 Preventive Medicine for Pets Market Drivers & Opportunity
1.3.3 Preventive Medicine for Pets Market Challenges
1.3.4 Preventive Medicine for Pets Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preventive Medicine for Pets Players Revenue Ranking (2023)
2.2 Global Preventive Medicine for Pets Revenue by Company (2019-2024)
2.3 Global Preventive Medicine for Pets Players Sales Volume Ranking (2023)
2.4 Global Preventive Medicine for Pets Sales Volume by Company Players (2019-2024)
2.5 Global Preventive Medicine for Pets Average Price by Company (2019-2024)
2.6 Key Manufacturers Preventive Medicine for Pets Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Preventive Medicine for Pets Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Preventive Medicine for Pets
2.9 Preventive Medicine for Pets Market Competitive Analysis
2.9.1 Preventive Medicine for Pets Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Preventive Medicine for Pets Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Medicine for Pets as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Powder
3.1.2 Liquid
3.2 Global Preventive Medicine for Pets Sales Value by Type
3.2.1 Global Preventive Medicine for Pets Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preventive Medicine for Pets Sales Value, by Type (2019-2030)
3.2.3 Global Preventive Medicine for Pets Sales Value, by Type (%) (2019-2030)
3.3 Global Preventive Medicine for Pets Sales Volume by Type
3.3.1 Global Preventive Medicine for Pets Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Preventive Medicine for Pets Sales Volume, by Type (2019-2030)
3.3.3 Global Preventive Medicine for Pets Sales Volume, by Type (%) (2019-2030)
3.4 Global Preventive Medicine for Pets Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cat
4.1.2 Dog
4.1.3 Reptile
4.1.4 Other
4.2 Global Preventive Medicine for Pets Sales Value by Application
4.2.1 Global Preventive Medicine for Pets Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preventive Medicine for Pets Sales Value, by Application (2019-2030)
4.2.3 Global Preventive Medicine for Pets Sales Value, by Application (%) (2019-2030)
4.3 Global Preventive Medicine for Pets Sales Volume by Application
4.3.1 Global Preventive Medicine for Pets Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Preventive Medicine for Pets Sales Volume, by Application (2019-2030)
4.3.3 Global Preventive Medicine for Pets Sales Volume, by Application (%) (2019-2030)
4.4 Global Preventive Medicine for Pets Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Preventive Medicine for Pets Sales Value by Region
5.1.1 Global Preventive Medicine for Pets Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preventive Medicine for Pets Sales Value by Region (2019-2024)
5.1.3 Global Preventive Medicine for Pets Sales Value by Region (2025-2030)
5.1.4 Global Preventive Medicine for Pets Sales Value by Region (%), (2019-2030)
5.2 Global Preventive Medicine for Pets Sales Volume by Region
5.2.1 Global Preventive Medicine for Pets Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Preventive Medicine for Pets Sales Volume by Region (2019-2024)
5.2.3 Global Preventive Medicine for Pets Sales Volume by Region (2025-2030)
5.2.4 Global Preventive Medicine for Pets Sales Volume by Region (%), (2019-2030)
5.3 Global Preventive Medicine for Pets Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Preventive Medicine for Pets Sales Value, 2019-2030
5.4.2 North America Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Preventive Medicine for Pets Sales Value, 2019-2030
5.5.2 Europe Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Preventive Medicine for Pets Sales Value, 2019-2030
5.6.2 Asia Pacific Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Preventive Medicine for Pets Sales Value, 2019-2030
5.7.2 South America Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Preventive Medicine for Pets Sales Value, 2019-2030
5.8.2 Middle East & Africa Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preventive Medicine for Pets Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preventive Medicine for Pets Sales Value
6.2.1 Key Countries/Regions Preventive Medicine for Pets Sales Value, 2019-2030
6.2.2 Key Countries/Regions Preventive Medicine for Pets Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Preventive Medicine for Pets Sales Value, 2019-2030
6.3.2 United States Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preventive Medicine for Pets Sales Value, 2019-2030
6.4.2 Europe Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preventive Medicine for Pets Sales Value, 2019-2030
6.5.2 China Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preventive Medicine for Pets Sales Value, 2019-2030
6.6.2 Japan Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preventive Medicine for Pets Sales Value, 2019-2030
6.7.2 South Korea Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preventive Medicine for Pets Sales Value, 2019-2030
6.8.2 Southeast Asia Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preventive Medicine for Pets Sales Value, 2019-2030
6.9.2 India Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preventive Medicine for Pets Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Preventive Medicine for Pets Product Offerings
7.1.5 Zoetis Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Preventive Medicine for Pets Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Preventive Medicine for Pets Product Offerings
7.3.5 Merck Recent Development
7.4 Elanco
7.4.1 Elanco Company Information
7.4.2 Elanco Introduction and Business Overview
7.4.3 Elanco Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Elanco Preventive Medicine for Pets Product Offerings
7.4.5 Elanco Recent Development
7.5 Virbac
7.5.1 Virbac Company Information
7.5.2 Virbac Introduction and Business Overview
7.5.3 Virbac Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Virbac Preventive Medicine for Pets Product Offerings
7.5.5 Virbac Recent Development
7.6 Dechra Veterinary Products
7.6.1 Dechra Veterinary Products Company Information
7.6.2 Dechra Veterinary Products Introduction and Business Overview
7.6.3 Dechra Veterinary Products Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dechra Veterinary Products Preventive Medicine for Pets Product Offerings
7.6.5 Dechra Veterinary Products Recent Development
7.7 Ceva
7.7.1 Ceva Company Information
7.7.2 Ceva Introduction and Business Overview
7.7.3 Ceva Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ceva Preventive Medicine for Pets Product Offerings
7.7.5 Ceva Recent Development
7.8 Vetoquinol
7.8.1 Vetoquinol Company Information
7.8.2 Vetoquinol Introduction and Business Overview
7.8.3 Vetoquinol Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Vetoquinol Preventive Medicine for Pets Product Offerings
7.8.5 Vetoquinol Recent Development
7.9 Ouro Fino Saude
7.9.1 Ouro Fino Saude Company Information
7.9.2 Ouro Fino Saude Introduction and Business Overview
7.9.3 Ouro Fino Saude Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Ouro Fino Saude Preventive Medicine for Pets Product Offerings
7.9.5 Ouro Fino Saude Recent Development
7.10 Norbrook
7.10.1 Norbrook Company Information
7.10.2 Norbrook Introduction and Business Overview
7.10.3 Norbrook Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Norbrook Preventive Medicine for Pets Product Offerings
7.10.5 Norbrook Recent Development
7.11 Jindun
7.11.1 Jindun Company Information
7.11.2 Jindun Introduction and Business Overview
7.11.3 Jindun Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Jindun Preventive Medicine for Pets Product Offerings
7.11.5 Jindun Recent Development
7.12 Wuhan chopperlvya
7.12.1 Wuhan chopperlvya Company Information
7.12.2 Wuhan chopperlvya Introduction and Business Overview
7.12.3 Wuhan chopperlvya Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Wuhan chopperlvya Preventive Medicine for Pets Product Offerings
7.12.5 Wuhan chopperlvya Recent Development
7.13 CAHIC
7.13.1 CAHIC Company Information
7.13.2 CAHIC Introduction and Business Overview
7.13.3 CAHIC Preventive Medicine for Pets Sales, Revenue and Gross Margin (2019-2024)
7.13.4 CAHIC Preventive Medicine for Pets Product Offerings
7.13.5 CAHIC Recent Development
8 Industry Chain Analysis
8.1 Preventive Medicine for Pets Industrial Chain
8.2 Preventive Medicine for Pets Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preventive Medicine for Pets Sales Model
8.5.2 Sales Channel
8.5.3 Preventive Medicine for Pets Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Preventive Medicine for Pets Market Trends
    Table 2. Preventive Medicine for Pets Market Drivers & Opportunity
    Table 3. Preventive Medicine for Pets Market Challenges
    Table 4. Preventive Medicine for Pets Market Restraints
    Table 5. Global Preventive Medicine for Pets Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Preventive Medicine for Pets Revenue Market Share by Company (2019-2024)
    Table 7. Global Preventive Medicine for Pets Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Preventive Medicine for Pets Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Preventive Medicine for Pets Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Preventive Medicine for Pets Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Preventive Medicine for Pets Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Preventive Medicine for Pets
    Table 13. Global Preventive Medicine for Pets Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Medicine for Pets as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Preventive Medicine for Pets Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Preventive Medicine for Pets Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Preventive Medicine for Pets Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Preventive Medicine for Pets Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Preventive Medicine for Pets Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Preventive Medicine for Pets Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Preventive Medicine for Pets Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Preventive Medicine for Pets Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Preventive Medicine for Pets Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Preventive Medicine for Pets Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Preventive Medicine for Pets Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Preventive Medicine for Pets Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Preventive Medicine for Pets Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Preventive Medicine for Pets Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Preventive Medicine for Pets Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Preventive Medicine for Pets Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Preventive Medicine for Pets Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Preventive Medicine for Pets Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Preventive Medicine for Pets Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Preventive Medicine for Pets Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Preventive Medicine for Pets Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Preventive Medicine for Pets Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Preventive Medicine for Pets Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Preventive Medicine for Pets Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Preventive Medicine for Pets Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Preventive Medicine for Pets Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Preventive Medicine for Pets Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Preventive Medicine for Pets Sales Value by Region (2019-2024) & (%)
    Table 44. Global Preventive Medicine for Pets Sales Value by Region (2025-2030) & (%)
    Table 45. Global Preventive Medicine for Pets Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Preventive Medicine for Pets Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Preventive Medicine for Pets Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Preventive Medicine for Pets Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Preventive Medicine for Pets Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Preventive Medicine for Pets Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Preventive Medicine for Pets Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Preventive Medicine for Pets Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Preventive Medicine for Pets Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Preventive Medicine for Pets Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Preventive Medicine for Pets Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Preventive Medicine for Pets Sales Volume, (2025-2030) & (K Units)
    Table 57. Zoetis Company Information
    Table 58. Zoetis Introduction and Business Overview
    Table 59. Zoetis Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Zoetis Preventive Medicine for Pets Product Offerings
    Table 61. Zoetis Recent Development
    Table 62. Boehringer Ingelheim Company Information
    Table 63. Boehringer Ingelheim Introduction and Business Overview
    Table 64. Boehringer Ingelheim Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Boehringer Ingelheim Preventive Medicine for Pets Product Offerings
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Merck Preventive Medicine for Pets Product Offerings
    Table 71. Merck Recent Development
    Table 72. Elanco Company Information
    Table 73. Elanco Introduction and Business Overview
    Table 74. Elanco Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Elanco Preventive Medicine for Pets Product Offerings
    Table 76. Elanco Recent Development
    Table 77. Virbac Company Information
    Table 78. Virbac Introduction and Business Overview
    Table 79. Virbac Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Virbac Preventive Medicine for Pets Product Offerings
    Table 81. Virbac Recent Development
    Table 82. Dechra Veterinary Products Company Information
    Table 83. Dechra Veterinary Products Introduction and Business Overview
    Table 84. Dechra Veterinary Products Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Dechra Veterinary Products Preventive Medicine for Pets Product Offerings
    Table 86. Dechra Veterinary Products Recent Development
    Table 87. Ceva Company Information
    Table 88. Ceva Introduction and Business Overview
    Table 89. Ceva Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Ceva Preventive Medicine for Pets Product Offerings
    Table 91. Ceva Recent Development
    Table 92. Vetoquinol Company Information
    Table 93. Vetoquinol Introduction and Business Overview
    Table 94. Vetoquinol Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Vetoquinol Preventive Medicine for Pets Product Offerings
    Table 96. Vetoquinol Recent Development
    Table 97. Ouro Fino Saude Company Information
    Table 98. Ouro Fino Saude Introduction and Business Overview
    Table 99. Ouro Fino Saude Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Ouro Fino Saude Preventive Medicine for Pets Product Offerings
    Table 101. Ouro Fino Saude Recent Development
    Table 102. Norbrook Company Information
    Table 103. Norbrook Introduction and Business Overview
    Table 104. Norbrook Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Norbrook Preventive Medicine for Pets Product Offerings
    Table 106. Norbrook Recent Development
    Table 107. Jindun Company Information
    Table 108. Jindun Introduction and Business Overview
    Table 109. Jindun Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Jindun Preventive Medicine for Pets Product Offerings
    Table 111. Jindun Recent Development
    Table 112. Wuhan chopperlvya Company Information
    Table 113. Wuhan chopperlvya Introduction and Business Overview
    Table 114. Wuhan chopperlvya Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Wuhan chopperlvya Preventive Medicine for Pets Product Offerings
    Table 116. Wuhan chopperlvya Recent Development
    Table 117. CAHIC Company Information
    Table 118. CAHIC Introduction and Business Overview
    Table 119. CAHIC Preventive Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. CAHIC Preventive Medicine for Pets Product Offerings
    Table 121. CAHIC Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Preventive Medicine for Pets Downstream Customers
    Table 125. Preventive Medicine for Pets Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Preventive Medicine for Pets Product Picture
    Figure 2. Global Preventive Medicine for Pets Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Preventive Medicine for Pets Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Preventive Medicine for Pets Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Preventive Medicine for Pets Report Years Considered
    Figure 7. Global Preventive Medicine for Pets Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Preventive Medicine for Pets Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Preventive Medicine for Pets Revenue in 2023
    Figure 10. Preventive Medicine for Pets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Powder Picture
    Figure 12. Liquid Picture
    Figure 13. Global Preventive Medicine for Pets Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Preventive Medicine for Pets Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Preventive Medicine for Pets Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Preventive Medicine for Pets Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Preventive Medicine for Pets Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Cat
    Figure 19. Product Picture of Dog
    Figure 20. Product Picture of Reptile
    Figure 21. Product Picture of Other
    Figure 22. Global Preventive Medicine for Pets Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Preventive Medicine for Pets Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Preventive Medicine for Pets Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Preventive Medicine for Pets Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Preventive Medicine for Pets Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Preventive Medicine for Pets Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Preventive Medicine for Pets Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Preventive Medicine for Pets Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Preventive Medicine for Pets Sales Volume (%), (2019-2030)
    Figure 39. United States Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Preventive Medicine for Pets Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Preventive Medicine for Pets Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Preventive Medicine for Pets Sales Value by Application (%), 2023 VS 2030
    Figure 60. Preventive Medicine for Pets Industrial Chain
    Figure 61. Preventive Medicine for Pets Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS